These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35578799)

  • 1. Comparing Detection of Alzheimer's and Vascular Disease-Related Cognitive Impairment With Brief Cognitive Screens.
    Kanser RJ; VandenBussche Jantz AB; Logan PM; Bailey EK; Kamper JE
    J Neuropsychiatry Clin Neurosci; 2022; 34(4):361-366. PubMed ID: 35578799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of a short test (3MS-R) for detecting Alzheimer's disease].
    Alexopoulos P; Nadler K; Cramer B; Herpertz SC; Kurz A
    Fortschr Neurol Psychiatr; 2007 Dec; 75(12):728-36. PubMed ID: 17607642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the Mini-Mental State Examination and the modified Mini-Mental State Examination in the detection of mild cognitive impairment in older adults.
    Van Patten R; Britton K; Tremont G
    Int Psychogeriatr; 2019 May; 31(5):693-701. PubMed ID: 30021667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging.
    Roalf DR; Moberg PJ; Xie SX; Wolk DA; Moelter ST; Arnold SE
    Alzheimers Dement; 2013 Sep; 9(5):529-37. PubMed ID: 23260866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Validation Study of the Hong Kong Brief Cognitive Test for Screening Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Sun W; Wu Q; Chen H; Yu L; Yin J; Liu F; Tian R; Song B; Qu B; Xing M; Zhang N
    J Alzheimers Dis; 2022; 88(4):1523-1532. PubMed ID: 35811533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test.
    Allone C; Lo Buono V; Corallo F; Bonanno L; Palmeri R; Di Lorenzo G; Marra A; Bramanti P; Marino S
    Psychogeriatrics; 2018 Mar; 18(2):123-131. PubMed ID: 29417704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
    Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
    BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?
    Pinto TCC; Machado L; Bulgacov TM; Rodrigues-Júnior AL; Costa MLG; Ximenes RCC; Sougey EB
    Int Psychogeriatr; 2019 Apr; 31(4):491-504. PubMed ID: 30426911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mini-Mental State Examination and Montreal Cognitive Assessment as Tools for Following Cognitive Changes in Alzheimer's Disease Neuroimaging Initiative Participants.
    Wang G; Estrella A; Hakim O; Milazzo P; Patel S; Pintagro C; Li D; Zhao R; Vance DE; Li W;
    J Alzheimers Dis; 2022; 90(1):263-270. PubMed ID: 36093696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué-Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010783. PubMed ID: 34313331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery.
    Kim J; Na HK; Byun J; Shin J; Kim S; Lee BH; Na DL
    Dement Geriatr Cogn Disord; 2017; 44(1-2):105-117. PubMed ID: 28768247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening.
    Horton DK; Hynan LS; Lacritz LH; Rossetti HC; Weiner MF; Cullum CM
    Clin Neuropsychol; 2015; 29(4):413-25. PubMed ID: 25978540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normative Data of Mini-Mental State Examination, Montreal Cognitive Assessment, and Alzheimer's Disease Assessment Scale-Cognitive Subscale of Community-Dwelling Older Adults in Taiwan.
    Wei YC; Chen CK; Lin C; Chen PY; Hsu PC; Lin CP; Shyu YC; Huang WY
    Dement Geriatr Cogn Disord; 2022; 51(4):365-376. PubMed ID: 35820405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting conversion of patients with Mild Cognitive Impairment to Alzheimer's disease using bedside cognitive assessments.
    Clarke A; Ashe C; Jenkinson J; Rowe O; A D N I ; Hyland P; Commins S
    J Clin Exp Neuropsychol; 2022 Dec; 44(10):703-712. PubMed ID: 36803664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Accuracy of Cognitive Screening Tests in Detecting Dementia Associated with Alzheimer's Disease: A Hierarchical Bayesian Latent Class Meta-Analysis.
    Wang X; Li F; Gao Q; Jiang Z; Abudusaimaiti X; Yao J; Zhu H
    J Alzheimers Dis; 2022; 87(1):285-304. PubMed ID: 35275533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of the efficiency of the mini-Kingston standardized cognitive assessment-revised in classifying patients according to DSM-5 major and mild neurocognitive disorders due to possible Alzheimer's disease.
    Heinik J; Kavé G
    Int Psychogeriatr; 2015 May; 27(5):785-91. PubMed ID: 25597552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.